FIELD: pharmaceutics.
SUBSTANCE: invention relates to a compound of formula (I) or to its pharmaceutically acceptable salt, where each of R1-R3, R9, R10 and R13-R15 is independently selected from hydrogen or deuterium, and R4–R8, R11, R12 and R16-R18 are hydrogen. The invention also relates to a pharmaceutical composition for inhibiting FAK based on the specified compound of formula (I).
EFFECT: new compounds and a pharmaceutical composition based on them have been obtained that can be used in medicine to obtain anti-cancer drugs.
(I)
10 cl, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FAK INHIBITOR AND DRUG COMBINATIONS THEREWITH | 2019 |
|
RU2820555C2 |
| HALOGEN-SUBSTITUTED PHENYLATE COMPOUND AND USE THEREOF | 2020 |
|
RU2820475C2 |
| PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
| OBTAINING AND USING TRICYCLIC PYRIMIDINONE COMPOUND AND COMPOSITION THEREOF | 2021 |
|
RU2820903C1 |
| DERIVATIVE OF PYRIMIDINE AND A FIVE-MEMBERED NITROGEN-CONTAINING HETEROCYCLE, METHOD FOR PRODUCTION AND MEDICAL APPLICATIONS THEREOF | 2019 |
|
RU2775229C1 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| COMPOUNDS WITH SPIRO AND AROMATIC RINGS AND APPLICATION THEREOF | 2019 |
|
RU2781100C1 |
| TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVE SALTS, METHODS FOR PREPARING THEM AND MEDICAL APPLICATION THEREOF | 2010 |
|
RU2523543C2 |
| C26-LINKED ANALOGUES OF RAPAMYCIN AS MTOR INHIBITORS | 2019 |
|
RU2826559C2 |
| HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
